Keeping in mind strategies to handle the third Covid-19 wave and studies showing positive results in the use of the Cocktail Antibody Therapy, the State Task Force has said it will play a key role in treatment. However, it has expressed concern over the pricing and has requested the government to make it affordable. The therapy costs around Rs 63,000 per patient. It has been seen as a replacement for plasma therapy.

More and more studies have shown favourable results and proved that the Cocktail Antibody Therapy is a life-saving drug. The cost has been a concern and we have requested the government to see if the GST can be waived off or if it can be subsidised so that more people can afford it,” said a State Task Force member.